Severe acute respiratory syndrome coronavirus 2–induced direct cytopathic effects against
type I and II pneumocytes mediate lung damage. Krebs von den Lungen‐6 (KL‐6) is mainly …

Background While SARS-CoV-2 similarly infects men and women, COVID-19 outcome is less
favorable in men. Variability in COVID-19 severity may be explained by differences in the …

Background Pirfenidone and nintedanib are the sole pharmacological therapies currently
approved for idiopathic pulmonary fibrosis (IPF). Limited comparison data is available in …

Idiopathic pulmonary fibrosis is characterised by abnormal reepithelialisation and remodelling
consequent to persistent stimuli or injury. The involvement of oxidative stress in alveolar …

… Correspondence should be addressed to Laura Bergantini; bergantini@student.unisi.it …
Data are available from Laura Bergantini (bergantini@student.unisi.it) and Elena …

Background: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease. In this
disease, interstitial lung diseases (ILD) is associated with high risk of mortality. Rituximab, a …

Idiopathic pulmonary fibrosis (IPF) is a fibroproliferative disorder limited to the lung. New
findings, starting from our proteomics studies on IPF, suggest that systemic involvement with …

Background Baricitinib is a JAK inhibitor that blocks intracellular signalling pathways of
inflammatory cytokines recommended for Rheumatoid arthritis (RA) patients not responding to …

Bronchoalveolar lavage (BAL) is a useful procedure for differential diagnosis of interstitial
lung diseases (ILDs) and for identification of granulomatous lung diseases. We investigated a …

Background Serum chitotriosidase is a promising biomarker that has shown high specificity
and sensitivity in patients with sarcoidosis. The aim of this study was to investigate …